EVIDENCE NETWORK — TWO-MINUTE REHEARSAL SCRIPT
221 spoken words. Target finish 1:55; leave five seconds spare.

Open https://nichfoster.com/pitch/ directly. Home resets to the title and 2:00.
Press T as you begin speaking. Right / Page Down advances; seven advances reach
the close. N toggles notes (visible to the audience); F requests fullscreen.
The clock also starts on the first advance if you have not pressed T.
The four demo moments are built into slide 3; no tab switch is needed.
Keep the interactive demo and the longer film for questions. Open the hosted
demo once beforehand if you intend to show it; its container may need to wake.
These are pacing cues, not an automatic slideshow or a measured oral rehearsal.

0:00 — Title
A biotech is choosing its next experiment. Another lab may already hold the answer, but sharing its underlying data is difficult. Evidence Network lets it sell a permitted answer. Keep the data. Trade the insight.

0:15 — Problem
Before repeating an assay, ask whether a partner already has useful evidence. The buyer decides what matters, what it is worth, and whether the source needs checking.

0:30 — Demo: permitted output
This is a recorded synthetic example. The owner declares which fields may leave and who can receive them. The raw source table stays with its owner.

0:43 — Demo: context and conflict
Sources are checked for this task, on only two reference cases. Two labs disagree. Both claims stay visible.

0:55 — Demo: value and price
Verification is a purchase too. Here the check costs one simulated credit and supports the source. The answer is valued at about eight credits and costs three.

1:10 — Demo: decision
Only the permitted answer and metadata are delivered. Candidate B becomes eligible under this model. That is not biological validation.

1:20 — Proof
The recorded checks verified all thirty-six signed envelopes and rejected an altered copy. Ten duplicate deliveries added no confidence or charge. Signatures prove who signed the bytes, not that the science is right.

1:40 — Ask
We start with one biotech, its existing contract research organization, and one endpoint. The business is a scoped pilot followed by a collaboration workspace. We are looking for one team willing to test that workflow.